Free Piantadosi leaves Cedars-Sinai for Alliance and Harvard April 20, 2018Vol.44 No.16By Paul Goldberg
Clinical RoundupFree Keytruda combination improved OS regardless of PD-L1 expression, including patients who tested negative for PD-L1 April 20, 2018Vol.44 No.16
Clinical RoundupFree Keytruda reduced risk of recurrence or death by over 40% vs. placebo as adjuvant therapy in resected, high-risk stage III melanoma April 20, 2018Vol.44 No.16
Clinical RoundupFree SU2C researchers find treatment strategy for stage I-III NSCLC April 20, 2018Vol.44 No.16
FreeIn Brief St. Baldrick’s commits $8 million to SU2C Pediatric Cancer Dream Team April 20, 2018Vol.44 No.16
FreeIn Brief Isabella Santos Foundation gives $5 million for rare & solid tumor program at Levine Children’s Hospital April 20, 2018Vol.44 No.16
FreeIn Brief MedStar Georgetown offers proton therapy with HYPERSCAN technology for adults and kids with cancer April 20, 2018Vol.44 No.16
FreeIn Brief Reprocell and Fox Chase to open biosample repository in India April 20, 2018Vol.44 No.16
Free Sharpless adds $100 million to NCI’s RPG pool,R01s for young investigators boosted by 25% April 20, 2018Vol.44 No.16By Matthew Bin Han Ong
